Vulcan Materials (NYSE: VMC) has completed the divestiture of its California ready-mixed concrete operations and acquired the southern Colorado and Dallas-Fort Worth operations of Brannan Sand & Gravel. This strategic move includes a rail-connected aggregate quarry with long-term reserves in Lamar, Colorado, and a new distribution yard in Dallas-Fort Worth, aligning with Vulcan's aggregates-led growth strategy. The company emphasized that these portfolio actions enhance its distribution network and expand its reach into key markets to meet growing customer demand for high-quality aggregates.

Caterpillar Inc. (CAT) shares have seen significant growth, up 165% over the past year, partly due to the artificial intelligence boom boosting demand for its power generation products for data centers. Despite a high forward P/E ratio compared to its sector average, Evercore ISI reiterated a "Buy" rating and raised its price target, acknowledging the company's integral role in data center construction. However, Jim Cramer views the stock as potentially overheated, suggesting its valuation resembles a tech stock, while Insider Monkey believes other AI stocks might offer better short-term returns.

ASML Holding N.V. (NASDAQ:ASML) is highlighted as a significant AI stock in Ken Fisher's portfolio. The company is a crucial provider of high-end EUV chip manufacturing machines, making it indispensable for producing the latest tech products and benefiting from the AI spending boom. ASML's shares have seen substantial growth, and its forward P/E ratio is competitive within the semiconductor equipment sector.

Mariska Hargitay is honoring her father, Mickey Hargitay, in a new Bristol Myers Squibb (BMS) awareness campaign called "Investigating Myeloma." Her father died 20 years ago from multiple myeloma, and Hargitay aims to educate others about the disease and inspire hope through medical advances. This campaign marks the first time Hargitay has spoken publicly about her father's battle with multiple myeloma, a cause shared by BMS's global oncology commercialization VP, Monica Shaw.

Best Buy is partnering with Meta to launch "Meta Lab @ Best Buy" in over 50 of its stores this summer. These 900-square-foot spaces will offer customers hands-on experiences with Meta's AI glasses and VR headsets through interactive demos and smart mirrors, guided by dedicated Meta Sales Specialists. The initiative aims to enhance customer experience by allowing them to try out cutting-edge technology before purchasing.

ATI Inc. has appointed Rob Rengel as its new Vice President of Investor Relations, effective June 22, 2026. Rengel, who previously served as Senior Director of Investor Relations at Caterpillar Inc., succeeds David Weston upon his retirement. Adam Pechart has also rejoined ATI's Investor Relations team as Director.

Over the past year, insiders at Wells Fargo & Company (NYSE:WFC) have sold US$10 million worth of stock, which could signal caution to investors. The largest transaction involved Senior EVP & General Counsel Ellen Patterson selling US$5.2 million worth of shares at a price near the current share price. While insider selling doesn't always indicate a problem, multiple sales over time can be a red flag, prompting shareholders to pay attention.

ATI Inc. (NYSE: ATI) has appointed Rob Rengel as Vice President of Investor Relations, effective June 22, 2026, succeeding David Weston who is retiring. Rengel, who previously held senior finance and investor relations roles at Caterpillar, will report to CFO James R. Foster, with Adam Pechart rejoining the IR team as Director. This change follows recent capital markets activity and strong operating performance for ATI.

Exxon Mobil Corporation (XOM) shares have risen significantly over the past year, with shareholders approving a headquarters move to Texas. The company, a major holding for Clearbridge Dividend Strategy, benefits from higher oil prices and robust production growth. While XOM is considered a strong investment, Insider Monkey suggests that some AI stocks may offer greater upside potential in a shorter timeframe.

Mariska Hargitay has partnered with Bristol Myers Squibb (BMS) to launch "Investigating Myeloma," an awareness campaign dedicating to highlighting the importance of scientific research in multiple myeloma. This initiative honors her father, Mickey Hargitay, who passed away from the disease 20 years ago, and focuses on new science like CELMoD research. The campaign aims to raise awareness about this complex blood cancer and offer hope to patients and their families through continued investigation into new treatment approaches.